Literature DB >> 2500620

Potassium uptake in muscle during paramyotonic weakness.

R T Moxley1, K Ricker, W J Kingston, R Böhlen.   

Abstract

Previous studies have suggested that an abnormal release of potassium from muscle may accompany attacks of paramyotonic weakness. We investigated 3 patients with paramyotonia congenita before and after the induction of forearm muscle weakness by exercise in cold water. Two of these patients had paralysis periodica paramyotonica and the 3rd had paramyotonia congenita. At the time of paramyotonic weakness there was a marked increase in the arterialized-venous concentration difference of potassium across forearm muscle. This indicated a significant uptake of potassium by forearm muscle in all 3 patients. Normal controls showed a slight release of potassium both at rest and after exercise in cold water. These results suggest that (1) the sodium-potassium pump of the muscle fiber is operating efficiently during paramyotonic weakness; and (2) there is a different mechanism responsible for the generalized weakness that occurs in hyperkalemic periodic paralysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500620     DOI: 10.1212/wnl.39.7.952

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Channelopathies.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17.

Authors:  M C Koch; K Ricker; M Otto; T Grimm; K Bender; B Zoll; P S Harper; F Lehmann-Horn; R Rüdel; E P Hoffman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

3.  Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus.

Authors:  L J Ptacek; J S Trimmer; W S Agnew; J W Roberts; J H Petajan; M Leppert
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

Review 4.  The nondystrophic myotonias.

Authors:  Chad R Heatwole; Richard T Moxley
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

5.  Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.

Authors:  Silvia Corrochano; Roope Männikkö; Peter I Joyce; Philip McGoldrick; Jessica Wettstein; Glenda Lassi; Dipa L Raja Rayan; Gonzalo Blanco; Colin Quinn; Andrianos Liavas; Arimantas Lionikas; Neta Amior; James Dick; Estelle G Healy; Michelle Stewart; Sarah Carter; Marie Hutchinson; Liz Bentley; Pietro Fratta; Andrea Cortese; Roger Cox; Steve D M Brown; Valter Tucci; Henning Wackerhage; Anthony A Amato; Linda Greensmith; Martin Koltzenburg; Michael G Hanna; Abraham Acevedo-Arozena
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.